NM_004463.3:c.2816A>C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2

The NM_004463.3(FGD1):​c.2816A>C​(p.Glu939Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000208 in 1,209,504 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 74 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00049 ( 0 hom., 15 hem., cov: 22)
Exomes š‘“: 0.00018 ( 0 hom. 59 hem. )

Consequence

FGD1
NM_004463.3 missense

Scores

5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 3.16
Variant links:
Genes affected
FGD1 (HGNC:3663): (FYVE, RhoGEF and PH domain containing 1) This gene encodes a protein that contains Dbl (DH) and pleckstrin (PH) homology domains and is similar to the Rho family of small GTP-binding proteins. The encoded protein specifically binds to the Rho family GTPase Cdc42Hs and can stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. Defects in this gene are the cause of the faciogenital dysplasia in Aarskog-Scott syndrome and a syndromatic form of X-linked cognitive disability. [provided by RefSeq, Jul 2017]
TSR2 (HGNC:25455): (TSR2 ribosome maturation factor) The protein encoded by this gene appears to repress the transcription of NF-kappaB and may be involved in apoptosis. Defects in this gene are a cause of Diamond-Blackfan anemia. [provided by RefSeq, Oct 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PP2
Missense variant in the FGD1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 11 curated pathogenic missense variants (we use a threshold of 10). The gene has 24 curated benign missense variants. Gene score misZ: 3.5183 (above the threshold of 3.09). GenCC associations: The gene is linked to Aarskog-Scott syndrome, X-linked.
BP4
Computational evidence support a benign effect (MetaRNN=0.009158999).
BP6
Variant X-54446179-T-G is Benign according to our data. Variant chrX-54446179-T-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 287068.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=1}.
BS2
High Hemizygotes in GnomAd4 at 15 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGD1NM_004463.3 linkc.2816A>C p.Glu939Ala missense_variant Exon 18 of 18 ENST00000375135.4 NP_004454.2 P98174A0A024R9Y5
TSR2NM_058163.3 linkc.*1629T>G 3_prime_UTR_variant Exon 5 of 5 ENST00000375151.5 NP_477511.1 Q969E8A0A024R9U9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGD1ENST00000375135.4 linkc.2816A>C p.Glu939Ala missense_variant Exon 18 of 18 1 NM_004463.3 ENSP00000364277.3 P98174
TSR2ENST00000375151.5 linkc.*1629T>G 3_prime_UTR_variant Exon 5 of 5 1 NM_058163.3 ENSP00000364293.4 Q969E8

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
53
AN:
112021
Hom.:
0
Cov.:
22
AF XY:
0.000380
AC XY:
13
AN XY:
34211
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000283
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00198
GnomAD3 exomes
AF:
0.000250
AC:
45
AN:
180227
Hom.:
0
AF XY:
0.000215
AC XY:
14
AN XY:
65233
show subpopulations
Gnomad AFR exome
AF:
0.00132
Gnomad AMR exome
AF:
0.000404
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000537
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000199
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000179
AC:
196
AN:
1097432
Hom.:
0
Cov.:
31
AF XY:
0.000163
AC XY:
59
AN XY:
362840
show subpopulations
Gnomad4 AFR exome
AF:
0.00220
Gnomad4 AMR exome
AF:
0.000541
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000111
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000113
Gnomad4 OTH exome
AF:
0.000391
GnomAD4 genome
AF:
0.000491
AC:
55
AN:
112072
Hom.:
0
Cov.:
22
AF XY:
0.000438
AC XY:
15
AN XY:
34272
show subpopulations
Gnomad4 AFR
AF:
0.00136
Gnomad4 AMR
AF:
0.000282
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000132
Gnomad4 OTH
AF:
0.00196
Alfa
AF:
0.000235
Hom.:
4
Bravo
AF:
0.000612
ESP6500AA
AF:
0.000782
AC:
3
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.000264
AC:
32

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

FGD1: PP2, BS2 -

Mar 31, 2016
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Jan 31, 2017
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

FGD1-related disorder Benign:1
Jul 19, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.0092
T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
0.69
N
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.12
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.019
D
Polyphen
0.0050
B
Vest4
0.23
MVP
0.59
MPC
2.0
ClinPred
0.059
T
GERP RS
5.3
Varity_R
0.26
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147012050; hg19: chrX-54472612; API